CTSO CytoSorbents Corporation Market Cap to Net Assets Ratio

Official company branding of cytosorbents.com (CTSO)

Cytosorbents (CTSO) develops high-tech blood purification filters, seeking FDA clearance for the DrugSorb-ATR system and increasing the sale of consumables in Europe. The market share price trend, recorded at -18.88, complements data regarding a loyal development team and the recruitment of sales experts. The business relies on partnerships with intensive care specialists through educational programs and joint research.

CTSO cytosorbents.com: Market Value to Book Value in the range 07/04/2022 - 10/27/2026
Original product of Cytosorbents

Cytosorbents is implementing automated digital monitoring into the production of blood purification cartridges. By analyzing the company's relative capitalization ratio, an investor can see the relationship between the business's market value and its actual net assets. This metric separates speculative price volatility from fundamental changes in capital. An increase in this indicator signals that the market is revaluing the company's technological potential. This allows for the determination of the fair value of shares relative to the balance sheet.

Competitor analysis

Market Value to Book Value Ratio DXCM|Market-to-Book Ratio penumbrainc.com|Novanta (NOVT) - Market Cap to Net Assets Ratio|Market Cap to Book Value Multiple Haemonetics Corp|Inspire Sleep (INSP) - Market Capitalization to Book Value Ratio|Market Value to Book Value Procept (PRCT)|CNMD: Market Capitalization to Book Value Ratio|pulsebiosciences.com - Market-to-Book Ratio|Market Value to Book Value Ratio InMode (INMD)|PMI - Market Value to Book Value|SRDX: Market Capitalization to Book Value Ratio|SENS (Senseonics Holdings, Inc.) - Market Capitalization to Book Value Ratio|Market Value to Book Value Ratio NeuroPace, Inc. NPCE|Market Capitalization to Net Assets Tactile Systems Technology Inc.|SANUWAVE - Market Capitalization to Book Value Ratio|Market-to-Book Ratio Outset Medical Inc OM|Market Cap to Net Assets Ratio ELMD (Electromed)|LNSR - Market Capitalization to Book Value Ratio|Market Cap to Net Assets Ratio AVITA Medical, Inc. RCEL|PROF - Market Cap to Book Value Multiple|bairdmed.com - Market Capitalization to Book Value Ratio|EDAP TMS (EDAP) - Market Capitalization to Book Value|Market Capitalization to Book Value Ratio APYX|Market Cap to Net Assets Ratio IceCure Medical, Ltd. (ICCM)|Pulmonx Corporation (LUNG) - Market Cap to Net Assets Ratio|Market Value to Book Value TELA (telabio.com)|Sensus Healthcare - Market Value to Book Value Ratio|Market Cap to Net Assets Ratio Zynex Medical ZYXI|ECOR (electroCore Medical) - Market Capitalization to Book Value Ratio|RBOT - Market-to-Book Ratio|Market Capitalization to Book Value Ratio inspira-technologies.com|seastarmedical.com (ICU) - Capitalization to Book Value Ratio|IRIX: Market Capitalization to Book Value Ratio|Market Capitalization to Book Value Intelligent Bio|Market Capitalization to Book Value Ratio XAIR (Beyond Air, Inc.)|Market Cap to Net Assets Ratio Profusa, Inc (PFSA)|Market Capitalization to Book Value Ratio SSKN (STRATA Skin Sciences, Inc.)|GlucoTrack Inc. - Market Capitalization to Book Value Ratio|NAOV - Market Value to Book Value Ratio|Venus Concept Inc (VERO) - Market Value to Book Value Ratio|Market Cap to Net Assets Ratio CHF Solutions NUWE|Aethlon Medical Corp (AEMD) - Market Value to Book Value|Market Capitalization to Book Value Ratio ASXC (Asensus Surgical Inc)|Market-to-Book Ratio AVGR|BSGM: Market Value to Book Value Ratio|Market Value to Equity Ratio Cutera Inc. CUTR|Market Cap to Net Assets Ratio KNW (Know Labs Corp)|Market Capitalization to Book Value Ratio Inari Medical Corp NARI|Market Capitalization to Book Value Ratio NVRO (Nevro Corp.)|RSLS: Market Capitalization to Book Value|Market Value to Book Value Ratio Silk Road Medical (SILK)